Crane NXT (CXT) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
6 Aug, 2026Executive summary
Achieved 22% year-over-year sales growth in Q2 2026, with 3% organic growth, driven by strong SAT performance and Antares Vision's contribution to DTT.
Adjusted EPS rose 13% year-over-year to $1.10, prompting an increase in full-year adjusted EPS guidance to $4.22–$4.42.
Integration of Antares Vision and De La Rue progressing well, supporting growth and margin expansion in DTT.
Record backlog and margin expansion in SAT and DTT segments, with operational improvements and restructuring actions underway.
Operating profit increased 43.8% to $68.9 million, with margin improvement to 14.0%.
Financial highlights
Q2 2026 sales reached $493 million, up 22% year-over-year; adjusted EBITDA was $115.5 million with a 23.4% margin.
Adjusted EPS for Q2 was $1.10, up from $0.97 in Q2 2025.
Net income attributable to common shareholders was $35.4 million, up from $24.9 million in Q2 2025.
Adjusted free cash flow was $79 million, with a conversion ratio of 124%.
Operating cash flow for the first six months was $72.7 million, up from $43.7 million prior year.
Outlook and guidance
Full-year 2026 sales growth expected at 15–17%; adjusted EBITDA margin guidance at ~24%.
Raised full-year adjusted EPS guidance to $4.22–$4.42.
SAT sales outlook increased to high single to low double-digit growth; DTT sales growth projected in the low 20s% range, with Antares Vision contributing $200–$210 million for the year.
Adjusted free cash flow conversion expected at 90–110%.
Quarterly dividend of $0.18 per share declared for Q3 2026.
Latest events from Crane NXT
- Record backlog, margin expansion, and ambitious 2028 targets drive a strong outlook.CXT
Oppenheimer 29th Annual Technology, Internet & Communications Conference - Board and auditor approvals passed; strong 2025 results and growth-focused 2026 outlook shared.CXT
AGM 2026 - Sales up 17% year-over-year, Adjusted EPS $0.60, and full-year sales guidance raised to 15%-17%.CXT
Q1 2026 - Board recommends electing nine directors, auditor ratification, and approving executive pay.CXT
Proxy filing - Targets ~$2.5B revenue and $600M EBITDA by 2028 through growth, M&A, and innovation.CXT
Investor Day 2026 - Sales up 11.4%, Adjusted EPS $4.06, 2026 outlook strong, dividend up 6%.CXT
Q4 2025 - Acquisition expands into regulated growth markets with strong synergies and financial upside.CXT
M&A Announcement - Q1 2025 sales up 5.3% to $330.3M; full-year sales growth guidance raised to 6–8%.CXT
Q1 2025 - 2024 results met expectations; 2025 outlook sees modest growth, margin headwinds, and ongoing diversification.CXT
Q4 2024